Article info

Download PDFPDF

Original article
Pseudomonas aeruginosa eradication therapy and risk of acquiring Aspergillus in young children with cystic fibrosis
Free

Authors

  1. Correspondence to Dr Stefanie Hennig, School of Pharmacy, The University of Queensland, Brisbane, QLD 4072, Australia; s.hennig{at}uq.edu.au
View Full Text

Citation

Harun SN, Holford NHG, Grimwood K On behalf of Australasian Cystic Fibrosis Bronchoalveolar Lavage (ACFBAL) study group, et al
Pseudomonas aeruginosa eradication therapy and risk of acquiring Aspergillus in young children with cystic fibrosis

Publication history

  • Received January 17, 2018
  • Revised March 31, 2019
  • Accepted May 8, 2019
  • First published June 15, 2019.
Online issue publication 
July 15, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.